An open study to determine the efficacy of Seenthil Chooranam in patients suffering from Rheumatoid Arthritis

Effectiveness of Seenthil Chooranam on Vali Azhal Keelvayu (Rheumatoid Arthritis)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/10/021572

Enrollment

Registered

2019-10-09

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified

Interventions

Intervention1: Seenthil Chooranam: 1 gm of Seenthil Chooranam will be administered twice a day with ghee for 60 days Control Intervention1: Not Applicable: Not Applicable

Eligibility

Inclusion criteria

Inclusion criteria: 1. Pain in major and minor joints 2. Morning stiffness 3. Swelling of joints 4. Tenderness 5. Patients with morphological changes in X-ray in cases of Rheumatoid arthritis 6. Patients with RA factor positive in blood investigation

Exclusion criteria

Exclusion criteria: 1. Other Autoimmune diseases 2. Patients receiving immunosuppressant, corticosteroids, cyclosporine, antipsychotics, osteoarthritis medications including painkillers 3. Pregnant women 4. Lactating women

Design outcomes

Primary

Measure	Time frame
Reduction in pain score which will be assessed by Universal Pain Scale, swelling and other clinical featuresTimepoint: 60 Days	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr S Rajamani

National Institute of Siddha

svisu11@gmail.com9962542755

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026